Reported Standalone quarterly numbers for Aarey Drugs and Pharmaceuticals are:Net Sales at Rs 76.48 crore in December 2023 up 22.42% from Rs. 62.47 crore in December 2022.
Quarterly Net Profit at Rs. 1.02 crore in December 2023 up 106.73% from Rs. 0.49 crore in December 2022.
EBITDA stands at Rs. 2.99 crore in December 2023 up 48.76% from Rs. 2.01 crore in December 2022.
Aarey Drugs EPS has increased to Rs. 0.40 in December 2023 from Rs. 0.19 in December 2022.
| Aarey Drugs shares closed at 49.30 on February 15, 2024 (NSE) and has given 7.76% returns over the last 6 months |
| Aarey Drugs and Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 76.48 | 57.83 | 62.47 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 76.48 | 57.83 | 62.47 | | EXPENDITURE | | Consumption of Raw Materials | 77.22 | 53.36 | 60.07 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -4.55 | 1.81 | -1.44 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.20 | 0.09 | 0.18 | | Depreciation | 0.47 | 0.41 | 0.55 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.91 | 0.72 | 2.14 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 2.23 | 1.44 | 0.98 | | Other Income | 0.29 | 0.84 | 0.48 | | P/L Before Int., Excpt. Items & Tax | 2.52 | 2.27 | 1.46 | | Interest | 1.06 | 1.27 | 0.71 | | P/L Before Exceptional Items & Tax | 1.47 | 1.01 | 0.75 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 1.47 | 1.01 | 0.75 | | Tax | 0.44 | 0.22 | 0.25 | | P/L After Tax from Ordinary Activities | 1.02 | 0.78 | 0.49 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.02 | 0.78 | 0.49 | | Equity Share Capital | 25.38 | 25.38 | 25.38 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.40 | 0.31 | 0.19 | | Diluted EPS | 0.40 | 0.31 | 0.19 | | EPS After Extra Ordinary | | Basic EPS | 0.40 | 0.31 | 0.19 | | Diluted EPS | 0.40 | 0.31 | 0.19 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
